FDA Approves First Companion Diagnostic Test to Simultaneously Screen for Multiple Non-Small Cell Lung Cancer Therapies

News   Jun 23, 2017 | Original story from Thermo Fisher Scientific

 
FDA Approves First Companion Diagnostic Test to Simultaneously Screen for  Multiple Non-Small Cell Lung Cancer Therapies
 
 
 
 

RELATED ARTICLES

Are Stem Cells the Link Between Bacteria and Cancer?

News

New mechanism of stomach gland regeneration reveals impact of Helicobacter pylori infection.

READ MORE

Biofortuna Raises £1.6 Million in Funding Round

News

Biofortuna Ltd has raised £1.6 million, allowing the company to take its blood group genotyping assays into clinical trails and commercialisation.

READ MORE

Cambridge Epigenetix, NuGEN Technologies Sign Agreement to Combine Leading Technologies in Epigenetics Research

News

Cambridge Epigenetix and NuGEN Technologies come together to integrate the oxidative bisulfite sequencing (oxBS-Seq) with NGS library preparation kits.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE